News & Insight

May 27, 2020 Studying the development of ovarian ca... Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of hig... read more
May 26, 2020 HUB Patient-Derived Organoids added to... San Diego, Calif – May 19, 2020 — Crown Bioscience today announced the expansion of their unique organoid platform w... read more
May 15, 2020 Organoid Virtual Mini-Symposium by STE... Join us on May 27 for a virtual mini-symposium with STEMCELL Technologies and HUB. Stay connected to your colleagues and... read more
May 13, 2020 Organoids allowing a deep look into th... Hormone-producing cells in the human gut are difficult to study, as they are very rare and unique to different species o... read more
May 01, 2020 SARS-CoV-2 infects cells in a human in... Researchers from the Hubrecht Institute in Utrecht, Erasmus MC University Medical Center Rotterdam, and Maastricht Unive... read more
April 01, 2020 A message from our CEO Dear valued customer, On Wednesday 11th March the World Health Organization (WHO) declared a pandemic in response to the... read more
February 21, 2020 Curing genetic disease in patient-deri... Whereas the CRISPR/Cas technology cuts out a defect in a gene and replaces it with a new piece, the latest CRISPR techno... read more
January 20, 2020 Applications of Organoid Technology 20... Biomedical Innovation Course Applications of Organoid Technology is a one-week intensive course offered by MDI Biologica... read more
December 10, 2019 HUB Organoids in Financial Times December 10, 2019. Yesterday the Financial Times featured an article on Organoid Innovation: Organoid innovation offers ... read more
October 18, 2019 CrownBio launched patient-derived tumo... San Diego, October 17, 2019 – Crown Bioscience today announced the launch of a new tumor organoid drug development pl... read more